Reviva Pharmaceuticals Holdings, Inc. Payments for Repurchase of Equity
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Reviva Pharmaceuticals Holdings, Inc. payments for repurchase of equity for the quarter ending 2020-11-30 was $109.13K.
- Reviva Pharmaceuticals Holdings, Inc. payments for repurchase of equity for the quarter ending 2020-08-31 was $0.00.
- Reviva Pharmaceuticals Holdings, Inc. payments for repurchase of equity for the quarter ending 2020-05-31 was $26.98M.
- Reviva Pharmaceuticals Holdings, Inc. payments for repurchase of equity for the quarter ending 2020-02-29 was $6.27M.
- Reviva Pharmaceuticals Holdings, Inc. payments for repurchase of equity for fiscal 2020 was $6.27M.
| Period end | Payments for Repurchase of Equity 3 month | Payments for Repurchase of Equity 12 month |
|---|---|---|
| 2020-11-30 | $109.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-01-14 | $33.36M derived: sum of 4 quarters · filed 2021-01-14 |
| 2020-08-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-10-14 | $33.25M derived: sum of 4 quarters · filed 2021-01-14 |
| 2020-05-31 | $26.98M 10-Q · filed 2020-07-07 | $33.25M derived: sum of 4 quarters · filed 2021-01-14 |
| 2020-02-29 | $6.27M derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-04 | $6.27M 10-K · filed 2020-05-04 |
| 2019-11-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-01-14 | |
| 2019-08-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-10-14 | |
| 2019-05-31 | $0.00 10-Q · filed 2020-07-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |